Results 31 to 40 of about 1,403,553 (284)

Maternal tobacco, cannabis and alcohol use during pregnancy and risk of adolescent psychotic symptoms in offspring [PDF]

open access: yes, 2009
Background Adverse effects of maternal substance use during pregnancy on fetal development may increase risk of psychopathology. Aims To examine whether maternal use of tobacco, cannabis or alcohol during pregnancy increases risk of offspring ...
David Gunnell   +20 more
core   +1 more source

Differences between bipolar disorder types 1 and 2 support the DSM two-syndrome concept

open access: yesInternational Journal of Bipolar Disorders, 2022
Objective To compare characteristics of bipolar disorder patients diagnosed as DSM-5 types I (BD-1) vs. II (BD-2). Methods We compared descriptive, psychopathological, and treatment characteristics in a sample of 1377 consenting, closely and repeatedly ...
Leonardo Tondo   +4 more
doaj   +1 more source

Can obsessions drive you mad? Longitudinal evidence that obsessive-compulsive symptoms worsen the outcome of early psychotic experiences [PDF]

open access: yes, 2010
Objective: Although there is substantial comorbidity between psychotic disorder and obsessive-compulsive disorder (OCD), little is known about how these clinical phenotypes, and their subclinical extended phenotypes, covary and impact on each other over ...
Os, J van   +20 more
core   +1 more source

Developing an international standard set of patient-reported outcome measures for psychotic disorders [PDF]

open access: yes, 2021
Objective: The objective of this project was to develop a set of patient-reported outcome measures for adolescents and adults who meet criteria for a psychotic disorder.
Jagger, Beth   +54 more
core   +2 more sources

Comprehensive review of multidimensional biomarkers in the ShangHai At Risk for Psychosis (SHARP) program for early psychosis identification

open access: yesPCN Reports, 2023
Psychosis is recognized as one of the largest contributors to nonfatal health loss, and early identification can largely improve routine clinical activity by predicting the psychotic course and guiding treatment.
TianHong Zhang   +8 more
doaj   +1 more source

Elevated pulse pressure and its associations with demographic and clinical parameters in a clinically representative sample of outpatients with psychotic disorders

open access: yesBJPsych Open, 2022
Elevated pulse pressure is associated with metabolic and neurocognitive diseases. Preliminary small-scale studies among patients with psychotic disorders have indicated that these patients had an increased pulse pressure compared with controls.
Christopher Holmberg   +2 more
doaj   +1 more source

Treatment Dilemmas in a Young Man Presenting with Narcolepsy and Psychotic Symptoms [PDF]

open access: yes, 2011
Psychotic features can be present in both narcolepsy and psychosis, which can result in challenges in diagnosis and management. The prevalence of both conditions is low and the reports in young people are scarce. Our report illustrates the relevance of a
Fernandez, V   +5 more
core   +1 more source

Differences in visual attention processing: An event-related potential comparative analysis within psychotic disorders [PDF]

open access: yes, 2018
>Magister Scientiae - MScIntroduction: Sustained attention is known to be dysfunctional in psychotic disorders. Sustained attention is the ability to remain focused on a specific time-locked stimulus within a task. We aimed to determine whether there are
Williams, Kimberley Clare
core   +1 more source

Evaluation of the relationship between vitamin D concentration and cognitive performance in community dwelling elderly people

open access: yesPsychiatria i Psychologia Kliniczna, 2019
Introduction: People over the age of 65 are at a significant risk of vitamin D deficiency. This a result of many factors. Based on the studies conducted so far, it can be concluded that there is a relationship between vitamin D deficiency and the elderly
Katarzyna Antczak-Domagała   +6 more
doaj   +1 more source

Sarcosine May Induce EGF Production or Inhibit the Decline in EGF Concentrations in Patients with Chronic Schizophrenia (Results of the PULSAR Study)

open access: yesPharmaceuticals, 2023
Sarcosine (N-methylglycine), a glutamatergic modulator, reduces the primary negative symptoms of schizophrenia. These beneficial changes might be mediated by trophic factors such as epidermal growth factor (EGF).
Agnieszka Pawlak   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy